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Collecting duct carcinoma (CDC) or Bellini duct car-
cinoma is a very rare and aggressive renal neoplasm
that arises from the principle cells lining the distal
collecting duct (Bellini duct) epithelium and the distal
renal tubules, unlike the much more common vari-
ants of renal cell carcinoma (RCC), which arise from
the convoluted tubules [1,2].
CDC accounts for approximately 0.4–1.8% of all
RCC and tends to occur in younger (median age at
diagnosis of 43 years), male (male-to-female ratio of
2:1) and white patients [3–7]. The term Bellini duct
carcinoma was first coined by Cromie et al [8]. Of all
renal epithelial neoplasms, CDC is the most aggressive.
Due to the rarity of this tumor and the lack of clinical
awareness, no diagnostic protocol has been established.
Concurrent RCC and urothelial carcinoma (UC) in one
person is rare and has seldom been reported [9–13].
Here, we report a very rare, newly diagnosed case
with combined bladder UC and renal CDC.
CASE PRESENTATION
A 68-year-old female patient was admitted to our hos-
pital in August 2005 because of intermittent painless
hematuria and left flank soreness. Abdominal ultraso-
nography revealed a left renal mass and hydronephro-
sis. Cystoscopic examination revealed a bladder tumor
and left side retrograde pyelography revealed a fill-
ing defect in the left renal pelvis with hydronephrosis
and hydroureter (Figure 1). Computed tomography
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The simultaneous occurrence of renal collecting duct (Bellini duct) carcinoma and bladder urothe-
lial carcinoma is very rare. A 68-year-old female patient with bladder urothelial carcinoma first
received transurethral resection of the tumor. Left side nephrouretectomy and transurethral
resection of the intramural ureter were performed 8 months later under the diagnosis of con-
comitant renal pelvic urothelial carcinoma. However, the final pathologic examination revealed
collecting duct carcinoma. The patient received systemic chemotherapy after surgery, but distant
metastasis was noted 6 months later. Here, we report a rare case of combined renal collecting
duct carcinoma and bladder urothelial carcinoma confirmed by pathologic examination and
immunohistochemical staining.
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(CT) revealed thickening of the posterior aspect of the
bladder wall with an uneven surface and heteroge-
neous enhanced soft tissue in the left renal pelvis with
renal parenchymal invasion (Figures 2 and 3). The
renal contour remained normal in the image study.
Transurethral resection of the bladder tumor was
performed as well as a left side ureteroscopic biopsy
with washing cytology. The results of pathologic exam-
ination of the bladder tumor revealed high-grade non-
invasive papillary UC, but the renal pelvis showed
chronic inflammation. However, cytologic examination
of the washing cytology showed a papillary urothelial
neoplasm of low malignant potential. Left nephroure-
tectomy with transurethral resection of the intramural
ureter and lymph node dissection were performed in
April 2006. Grossly, the tumor was diffusely distrib-
uted in the upper pole of the renal parenchyma with
a poorly defined margin and whitish color (Figure 4).
Microscopically, it showed multifocal tumor growth
with a tubular or tubulopapillary and solid pattern 
in which irregular angulated glands infiltrated the
renal parenchyma (Figure 5). The tumor cells were
hyperchromatic, pleomorphic and had distinct nu-
cleoli. Intratubular epithelial atypia adjacent to the
tumor was also seen. Immunohistochemical studies
demonstrated positive staining for cytokeratin (CK),
Figure 1. Left side retrograde pyelography shows a left renal
pelvis filling defect with hydroureter.
Figure 2. Computed tomography shows the posterior aspect of
bladder wall thickening with an uneven surface.
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Figure 3. Computed tomography shows heterogeneously enhanced soft tissue with renal parenchymal invasion in the left side renal
pelvis.
high-molecular-weight CK (HMWCK) and CD10 (focal
positive), and negative staining for vimentin (Figure 6).
The results of histologic and immunohistochemical
studies were consistent with CDC. The perirenal fat
and lymph nodes showed tumor invasion.
The patient was discharged on the seventh post-
operative day and started receiving systemic chemo-
therapy. The chemotherapy regimen that we chose was
active for the UC. Unfortunately, distant metastasis
was noted 6 months after surgery.
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Figure 4. The tumor, whitish in color with a poorly defined margin,
is diffusely distributed in the renal parenchyma, mainly in the
upper pole.
Figure 5. There is multifoci tumor growth with a tubular, tubu-
lopapillary or solid pattern, in which irregularly angulated glands
infiltrate the renal parenchyma (hematoxylin & eosin, 10×).
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Figure 6. (A) Positive cytokeratin staining. (B) Positive staining for high-molecular-weight cytokeratin. (C) Focal positive staining
for CD10. (D) Negative staining for vimentin.
DISCUSSION
The idea that the collecting duct epithelium may be 
a source of tumor development was first raised by
Mancilla-Jimenez et al in 1976 based on their finding
of atypical and hyperplastic changes in the adjacent
duct [14]. Patients with CDC are usually found to have
a family history of associated malignancies, including
colon, pancreas, lung, ovary and uterus cancers [15].
Hematuria, flank pain and a palpable mass are
the most common presenting features of CDC. Other
symptoms, such as fever, anorexia and body weight
loss, are also common, but no particular paraneoplas-
tic syndrome has been reported. CT scans generally
reveal that affected kidneys maintain a normal con-
tour with minimal contrast enhancement, and some-
times renal masses protruding into the central sinuses
may also be noted [16]. Magnetic resonance imaging
reveals heterogeneous low intensity masses [17]. Renal
angiography usually reveals hypovascular or avascu-
lar tumors [18,19]. A definitive diagnosis can only be
made by a detailed histopathologic examination [2].
Pathologically, the tumor is an adenocarcinoma and
consists of two components. The main tumor is pap-
illary with a fibrovascular core, and the invasive part
is composed of glandular elements associated with 
a marked desmoplastic reaction. Cytologically, CDC
shows malignant round-to-oval tumor cells with a
modest eosinophilic cytoplasm and a predominantly
papillary growth pattern. The tumor cells are columnar
and show variable degrees of pleomorphism. The histo-
logic diagnosis of CDC can be confirmed by positive
immunohistochemical staining with a collecting duct
marker, such as UEA-1 (Ulex europaeus agglutinin-1)
or HMWCK, and negative staining for vimentin [20].
CDC must be differentiated from some centrally
located renal lesion with infiltrative features, including
invasive transitional cell or squamous cell carcinoma,
lymphoma, renal metastasis, invasive RCC involv-
ing a column of Bertin, mesoblastic nephroma, renal
medullary carcinoma and bacterial pyelonephritis [21].
The prognosis of CDC is generally poor because
of its aggressive behavior and the advanced stage 
at the time of diagnosis. The standard treatment for
CDC of the kidney is radical nephrectomy because
no standard chemotherapy or immunotherapy regi-
men has been effective in the management of CDC.
Because of the close relationship between CDC and
UC (a common embryologic origin that arises from
the mesonephrons), chemotherapy may be considered
in the treatment of CDC [22].
Bladder UC is not rare in adults, but only a few
cases of CDC have been reported. The case of bladder
UC and concomitant renal pelvis CDC that we report
is very rare, even though the affected tissues have 
a common embryologic origin. Because of the poor
prognosis of the disease, distant metastasis was noted
6 months after the operation. Typically, CDC has an
aggressive course and many patients present with
metastasis soon after diagnosis.
In this paper, we report a newly diagnosed bladder
UC simultaneously with a renal CDC treated with
left nephrouretectomy plus transurethral resection of
the intramural ureter and transurethral resection of the
bladder tumor. Considering the aggressive character
of this tumor, systemic chemotherapy was arranged
for the patient after surgery, but unfortunately, dis-
tant metastasis occurred 6 months later. Due to the
rarity and poor prognosis of this kind of tumor, we
need more experience to be able to offer more effective
management and detect such tumors at an earlier
stage.
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